APPROFONDIMENTI
ricerca avanzata

Solifenacin Succinate versus Percutaneous Tibial Nerve Stimulation in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Crossover Study

2013 -

Vecchioli-Scaldazza C. Morosetti C. Berouz A. Giannubilo W. Ferrara V.

Solifenacin Succinate versus Percutaneous Tibial Nerve Stimulation in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Crossover Study

This study compared the effectiveness of solifenacin succinate (SS) versus percutaneous tibial nerve stimulation (PTNS) in women with overactive bladder syndrome (OABS)

Gynecol Obstet Invest (DOI: 10.1159/000350216) 

 


leggi tutto, scarica il documento pdf

Percutaneous posterior tibial nerve stimulation for Voiding Dysfunction

2011 -

B. Adile, G.Adile, D. Passalacqua, P. Speciale, M. Vella

Percutaneous posterior tibial nerve stimulation for Voiding Dysfunction

Pregnancy and childbirth, pelvic surgery and some medication (diuretics and anticholinergic), obesity, some neurological disease (Multiple-sclerosis, spinal cord injury, diabetes) are associated with urge incontinence as the long-held clinical impression confirmed. The aim of this study was to evaluate the efficacy of percutaneous tibial nerve stimulation (PTNS) for the treatment of complaints related to overactive bladder syndrome: urinary urgency, urinary frequency, urge incontinence (UI), non- obstructive urinary retention.

 


leggi tutto, scarica il documento pdf

Percutaneous tibial nerve stimulation

2010 -

MacDiarmid, S.A., Peters, K.M., & Wooldridge, L.S.

Percutaneous tibial nerve stimulation for the treatment of overactive bladder: treatment interval frequency.

The Overactive Bladder Innovative Therapy (OrBIT) Trial Phase 2 demonstrated the long term effectiveness of percutaneous tibial nerve stimulation (PTNS) for the treatment of overactive bladder (OAB). Symptom improvements after 12-weekly PTNS treatments were sustained throughout 12 months of therapy. The objective of this study was to evaluate the treatment interval frequency necessary to maintain efficacy.

Poster, Society for Urodynamics and Female Urology, St. Petersburg, FL.
 


leggi tutto, scarica il documento pdf

© 2010-2016 SUNMEDICAL S.r.l. - C.F./P. IVA 06548140968